Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Eid
Donald Trump
Nintendo
European Union
European Central Bank
Social Media
NATO
Senate
Regulation
World Cup
Taxes
psychiatrist.com image

News from psychiatrist.com

Information about psychiatrist.com

Where is psychiatrist.com located?psychiatrist.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top psychiatrist.com News

What is ketamine therapy? Mormon reality stars tout controversial treatment
United States · United States

What is ketamine therapy? Mormon reality stars tout controversial treatment

100% Right coverage: 1 sources
Ketamine therapy's role in treating depression and its controversial use by Jen and Zac Affleck in "The Secret Lives of Mormon Wives" highlights potential benefits and risks.See the Story
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?

What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?

The authors encourage the field to destigmatize the term “deprescribing” from its misappropriated usage, explicate its accurate definition, and reclaim its purposeful meaning.Read Article
Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders: A Longitudinal Study of 140,726 Participants
Taiwan · Taiwan

Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders: A Longitudinal Study of 140,726 Participants

Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders: A Longitudinal Study of 140,726 Participants Vestibular disorders are a common but often underestimated category of sensory deficits that affect the inner ear and central nervous system, which play a vital role in maintaining balance and spatial orientation. These disorders can lead to debilitating symptoms, such as vertigo, dizziness, imbalance, an…Read Article

Posterior Reversible Encephalopathy Syndrome Presenting With Obstructive Hydrocephalus: A Rare Presentation

Posterior Reversible Encephalopathy Syndrome Presenting With Obstructive Hydrocephalus: A Rare Presentation Posterior reversible encephalopathy syndrome (PRES) is an acute clinical condition, often manifesting as a spectrum of findings including headache, encephalopathy, visual disturbances, and seizures. The disorder is believed to result from failure of cerebral autoregulation and endothelial dysfunction, resulting in vasogenic cerebral edema.…Maryland · MarylandRead Article

Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review

Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review Hydroxychloroquine (HCQ) is a hydroxide derivative of chloroquine (CQ). It is approved by the US Food and Drug Administration (FDA) for treating malaria, systemic lupus erythematosus (SLE), discoid lupus erythematosus, and rheumatoid arthritis. The off-label uses include Q-fever, porphyria cutanea tarda, primary Sjogren disease, and sarcoidosis.1–4 Since CQ and HCQ exhi…Maryland · MarylandRead Article

Detecting Tardive Dyskinesia Using Video-Based Artificial Intelligence

Detecting Tardive Dyskinesia Using Video-Based Artificial Intelligence Tardive dyskinesia (TD) is a serious and often disabling neurological syndrome primarily caused by prolonged exposure to antipsychotic medications.1 It is characterized by involuntary, repetitive movements of the face, trunk, and extremities,2 such as grimacing, blinking, and abnormal posturing. Incidence rates are estimated at 2%–4% per year for second-generation antipsychot…Artificial Intelligence · ClevelandRead Article

Management of Psychotic Illnesses in Primary Care Settings

Management of Psychotic Illnesses in Primary Care Settings Have you ever struggled to manage patients who were acting strangely? Have you wondered how best to approach treatment when your patient was suspicious or paranoid? Have you been frustrated by patients who failed to adhere to their medical regimen due to a psychiatric illness? If you have, the following case vignette and discussion should prove useful. CASE VIGNETTE Mr A, a 45-year-old m…Mental Health · Palo AltoRead Article

Prediction of Adolescent Suicidal Events by Residual Depressive Symptoms After Intensive Treatment

Prediction of Adolescent Suicidal Events by Residual Depressive Symptoms After Intensive Treatment Suicide is the fourth leading cause of death globally for ages 15–29 years.1 In 2023, over 49,000 Americans died by suicide, with a rate of 13.5 per 100,000 for ages 15–24 years.2 Depression is a major risk factor, yet a meta-analysis revealed that predicting suicide attempts remains ineffective, highlighting the need to explore novel risk factors.…Dallas, Texas · DallasRead Article

Electroconvulsive Therapy Generates a Postictal Wave of Spreading Depolarization in Mice and Humans

100% Center coverage: 1 sources
Electroconvulsive therapy (ECT) is a fast-acting, highly effective, and safe treatment for medication-resistant depression. Historically, the clinical benefits of ECT have been attributed to generating a controlled seizure; however, the underlying neurobiology is understudied and unresolved. Using optical neuroimaging of neural activity and hemodynamics in a mouse model of ECT, we demonstrated that a second brain event follows seizure: cortical …See the Story

GLP-1 Agonists Market Set to Triple by 2033, Driven by Diabetes, Obesity & Beyond

The global glucagon-like peptide-1 (GLP-1) agonists market, valued at $31.3 billion in 2023, is on track to reach $90.6 billion by 2033, expanding at a robust CAGR of 11.2%. Initially developed for type 2 diabetes, GLP-1 agonists are rapidly reshaping treatment paradigms in obesity, cardiovascular health, and metabolic disorders—fueling one of the most dynamic pharmaceutical markets of the decade. 🔬 What Are GLP-1 Agonists? GLP-1 agonists are a…DiabetesSee the Story

Is It Munchausen or Is It Dementia?

Is It Munchausen or Is It Dementia? Factitious disorder (FD), also known as Munchausen syndrome, is a psychiatric condition characterized by the deliberate fabrication or exaggeration of medical or psychological symptoms, often without an apparent external reward. Individuals affected by FD may employ various methods to simulate or induce illness, including falsification, simulation, and the deliberate induction of symptoms. While a genuine medi…Maryland · MarylandRead Article

Breaking News Topics Related to psychiatrist.com

Maryland

Maryland

New York State

New York State

California, United States

California, United States

Health

Health

Mental Health

Mental Health

Canada

Canada

United States

United States

Medical

Medical

India

India

Research

Research

News
For You
SearchBlindspotLocal